0001559688-17-000002.txt : 20170621 0001559688-17-000002.hdr.sgml : 20170621 20170621145348 ACCESSION NUMBER: 0001559688-17-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 EFFECTIVENESS DATE: 20170621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MalarVx, Inc. CENTRAL INDEX KEY: 0001559688 IRS NUMBER: 455021055 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-232492 FILM NUMBER: 17922711 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH STREET 2: SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-200-8541 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH STREET 2: SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98109 D/A 1 primary_doc.xml X0707 D/A LIVE 0001559688 MalarVx, Inc. 307 WESTLAKE AVENUE NORTH SUITE 200 SEATTLE WA WASHINGTON 98109 206-200-8541 WASHINGTON None None Corporation true 2012 James Wayne Davie 307 Westlake Avenue North Suite 200 Seattle WA WASHINGTON 98109 Executive Officer Director Biotechnology $1 - $1,000,000 06b true 0001559688-15-000003 2015-01-02 true true false 25000 James W Davie None None None 307 Westlake Avenue North Suite 200 Seattle WA WASHINGTON 98109 CO COLORADO WA WASHINGTON false 1500000 1050000 450000 false 21 0 0 180000 true false MalarVx, Inc. James W. Davie James W Davie President & CEO 2017-06-21